Latest news
Why Is NTLA Stock Jumping 5% Premarket Today? - StocktwitsStocktwits · Sat, 08 Aug 2026 09:29:08 GMTIntellia Therapeutics (NASDAQ:NTLA) Stock Rating Lowered by Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 07:54:20 GMTNTLA SWOT Analysis: Financial Resilience Amidst Clinical Advancements Revealed in 10-Q Filing - GuruFocusGuruFocus · Sat, 08 Aug 2026 05:24:18 GMTIntellia Therapeutics | SCHEDULE 13G: Others - MoomooMoomoo · Fri, 07 Aug 2026 17:53:01 GMT‘Significant’ demand for Revolution drug; Intellia pinpoints liver toxicity culprit - BioPharma DiveBioPharma Dive · Fri, 07 Aug 2026 15:02:34 GMTNTLA Q2 Earnings In Line, Top Line Misses on Lower Regeneron Revenues - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 14:46:00 GMTState Street (NTLA) stake: 9.23M Intellia Therapeutics shares in 13G filing - Stock TitanStock Titan · Fri, 07 Aug 2026 13:55:17 GMTWill Phase III lonvo-z Data and Resumed ATTR Program Change Intellia Therapeutics' (NTLA) Narrative - simplywall.stsimplywall.st · Fri, 07 Aug 2026 13:40:06 GMT